LabCentral Golden Ticket
Roche's LabCentral Golden Ticket offers early-stage biotech startups a year of free lab space in Boston to accelerate research on innovative therapies.
Funder: Roche
Due Dates: Rolling
Funding Amounts: One year of free lab space at LabCentral in Boston (estimated value: full lab facilities and infrastructure for 12 months)
Summary: Supports early-stage biotech companies by providing a year of free lab space to accelerate research and development.
Key Information: Focused on innovative, early-stage biotech companies seeking to advance breakthrough therapies.
Description
The LabCentral Golden Ticket, sponsored by Roche, provides early-stage biotech companies with one year of fully subsidized lab space at LabCentral in Boston. This initiative is designed to accelerate the growth of innovative startups by giving them access to state-of-the-art laboratory facilities and a vibrant, collaborative ecosystem. The program reflects Roche's commitment to fostering scientific discovery and supporting the next generation of breakthrough therapies through strategic partnerships.
